CerRx Receives $1.1 Million NIH Grant for Cancer Study - MyHighPlains.com
CerRx, Inc. (CerRx) today [Thursday] announced that it has been awarded a non-diluting National Institute of Health (NIH) grant of $1.1M to support a Phase I study combining its two lead investigational compounds intravenous (IV) fenretinide and IV safingol. These drugs act together to specifically kill cancer cells by increasing certain toxic ‘ceramide’ waxes in cancer cells.
...
C. Patrick Reynolds, M.D., Ph.D., chief scientific officer of CerRx and director at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, said, “The combination of fenretinide plus safingol provides a very exciting and novel approach to selectively attacking cancer cells of many types in adults and children and we are delighted that this imporant clinical trial will be carried out here in Texas.”
Read the full story >>
Related Stories
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
TTUHSC School of Nursing to Celebrate New YWCA Location
Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.
Recent Stories
Medical Students Meet Their Match
March represents springtime, new beginnings and time for Match Day for fourth-year medical students nationwide. The Texas Tech University Health Sciences Center’s (TTUHSC) School of Medicine students participated in Match Day Friday (March 21).
Burnout and Compassion Fatigue: Health and Human Services
Dr. Elizabeth Chavez-Palacios, LPC-S, CRC, instructor for the Clinical Rehabilitation Counseling program at TTUHSC, discussed burnout and compassion fatigue.
Psychedelic Therapy: Jury’s Still Out
Dr. Michelle Shuler, an assistant professor in the Department of Clinical Counseling and Mental Health at TTUHSC, discussed psychedelic therapy.